Profile
Zachary Meisel is a Director of ZaBeCor Pharmaceutical Co. LLC and Biothorpe Pharmaceuticals.
He is a Faculty Member in the Department of Emergency Medicine at the University of Pennsylvania School of Medicine.
He has experience in asthma, allergy, infections, and arthritis.
Dr. Meisel received a BA degree from Columbia University and holds an MD and an MPH degree from Johns Hopkins University.
Zachary Meisel active positions
| Companies | Position | Start |
|---|---|---|
Biothorpe Pharmaceuticals | Director/Board Member | 2009-03-29 |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2009-03-29 |
Former positions of Zachary Meisel
| Companies | Position | End |
|---|---|---|
ZaBeCor Pharmaceutical LLC
ZaBeCor Pharmaceutical LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA, antisense and other molecular technologies | Director/Board Member | - |
Training of Zachary Meisel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
ZaBeCor Pharmaceutical LLC
ZaBeCor Pharmaceutical LLC BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that develops siRNA, antisense and other molecular technologies | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pennsylvania
University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Johns Hopkins University
The Johns Hopkins University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biothorpe Pharmaceuticals |
- Stock Market
- Insiders
- Zachary Meisel
















